Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01283945 |
| Title | Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Ethical Oncology Science |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA | FRA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Institute Gustave Roussy | Villejuif | Paris | 94805 | France | Details | |
| Hopital Louis Pradel | Lyon | 69677 | France | Details | ||
| European Institute of Oncology | Milano | 20141 | Italy | Details | ||
| Vall d' Hebron University Hospital | Barcellona | Spain | Details |